Exploring the Interaction Among EPHX1, GSTP1, SERPINE2, and TGFB1 Contributing to the Quantitative Traits of Chronic Obstructive Pulmonary Disease in Chinese Han Population

Overview

Journal Hum Genomics

Publisher Biomed Central

Specialty Genetics

Date 2016 May 20

PMID 27193053

Citations 6

Authors

Li An

Yingxiang Lin

Ting Yang

Lin Hua

Affiliations

Soon will be listed here.

Abstract

Background: Currently, the majority of genetic association studies on chronic obstructive pulmonary disease (COPD) risk focused on identifying the individual effects of single nucleotide polymorphisms (SNPs) as well as their interaction effects on the disease. However, conventional genetic studies often use binary disease status as the primary phenotype, but for COPD, many quantitative traits have the potential correlation with the disease status and closely reflect pathological changes.

Method: Here, we genotyped 44 SNPs from four genes (EPHX1, GSTP1, SERPINE2, and TGFB1) in 310 patients and 203 controls which belonged to the Chinese Han population to test the two-way and three-way genetic interactions with COPD-related quantitative traits using recently developed generalized multifactor dimensionality reduction (GMDR) and quantitative multifactor dimensionality reduction (QMDR) algorithms.

Results: Based on the 310 patients and the whole samples of 513 subjects, the best gene-gene interactions models were detected for four lung-function-related quantitative traits. For the forced expiratory volume in 1 s (FEV1), the best interaction was seen from EPHX1, SERPINE2, and GSTP1. For FEV1%pre, the forced vital capacity (FVC), and FEV1/FVC, the best interactions were seen from SERPINE2 and TGFB1.

Conclusion: The results of this study provide further evidence for the genotype combinations at risk of developing COPD in Chinese Han population and improve the understanding on the genetic etiology of COPD and COPD-related quantitative traits.

Citing Articles

Twenty years of changes in the definition of early chronic obstructive pulmonary disease.

Chen D, Curtis J, Chen Y Chin Med J Pulm Crit Care Med. 2024; 1(2):84-93.

PMID: 39170827 PMC: 11332824. DOI: 10.1016/j.pccm.2023.03.004.

and polymorphisms are associated with COPD risk: a systematic review and meta-analysis.

Yang Q, Huang W, Yin D, Zhang L, Gao Y, Tong J Front Genet. 2023; 14:1128985.

PMID: 37284064 PMC: 10239837. DOI: 10.3389/fgene.2023.1128985.

Whole-Exome Sequencing Implicates the rs777591A > G Intron Variant in Chronic Obstructive Pulmonary Disease in a Kashi Cohort.

Xu J, Li L, Ren J, Zhong X, Xie C, Zheng A Front Cell Dev Biol. 2022; 9:792027.

PMID: 35198563 PMC: 8859106. DOI: 10.3389/fcell.2021.792027.

The Cumulative Effect of Gene-Gene Interactions Between and Gene Polymorphisms Combined with Smoking on COPD Risk.

Ganbold C, Jamiyansuren J, Tumurbaatar A, Bayarmaa A, Enebish T, Dashtseren I Int J Chron Obstruct Pulmon Dis. 2021; 16:2857-2868.

PMID: 34707353 PMC: 8544116. DOI: 10.2147/COPD.S320841.

Association among genetic polymorphisms of GSTP1, HO-1, and SOD-3 and chronic obstructive pulmonary disease susceptibility.

Du Y, Zhang H, Xu Y, Ding Y, Chen X, Mei Z Int J Chron Obstruct Pulmon Dis. 2019; 14:2081-2088.

PMID: 31564855 PMC: 6736021. DOI: 10.2147/COPD.S213364.

References

Siedlinski M, Postma D, Smit H, Boezen H . No effects of EPHX1 polymorphisms on the level or change of FEV1 in the general population. Eur Respir J. 2009; 33(2):446-9. DOI: 10.1183/09031936.00144108. View

Briollais L, Wang Y, Rajendram I, Onay V, Shi E, Knight J . Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario. BMC Med. 2007; 5:22. PMC: 1976420. DOI: 10.1186/1741-7015-5-22. View

Kukkonen M, Tiili E, Vehmas T, Oksa P, Piirila P, Hirvonen A . Association of genes of protease-antiprotease balance pathway to lung function and emphysema subtypes. BMC Pulm Med. 2013; 13:36. PMC: 3680142. DOI: 10.1186/1471-2466-13-36. View

Ning W, Li C, Kaminski N, Feghali-Bostwick C, Alber S, Di Y . Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A. 2004; 101(41):14895-900. PMC: 522001. DOI: 10.1073/pnas.0401168101. View

Yuan W, He X, Xu Q, Wang H, Casaburi R . Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients. BMC Pulm Med. 2014; 14:16. PMC: 3938036. DOI: 10.1186/1471-2466-14-16. View

Yu W, Kwon M, Park T . Multivariate Quantitative Multifactor Dimensionality Reduction for Detecting Gene-Gene Interactions. Hum Hered. 2015; 79(3-4):168-81. DOI: 10.1159/000377723. View

. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View

Lakhdar R, Denden S, Knani J, Leban N, Daimi H, Hassine M . Combined analysis of EPHX1, GSTP1, GSTM1 and GSTT1 gene polymorphisms in relation to chronic obstructive pulmonary disease risk and lung function impairment. Dis Markers. 2011; 30(5):253-63. PMC: 3825482. DOI: 10.3233/DMA-2011-0782. View

Liu S, Tseng C, Tu M, Wang C, Tseng C, Chin C . The clinical COPD questionnaire correlated with BODE index-A cross-sectional study. ScientificWorldJournal. 2012; 2012:361535. PMC: 3361188. DOI: 10.1100/2012/361535. View

10.

Swanney M, Ruppel G, Enright P, Pedersen O, Crapo R, Miller M . Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008; 63(12):1046-51. DOI: 10.1136/thx.2008.098483. View

11.

Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N . Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004; 96(6):434-42. PMC: 7713993. DOI: 10.1093/jnci/djh075. View

12.

Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54(7):581-6. PMC: 1745516. DOI: 10.1136/thx.54.7.581. View

13.

Joos L, He J, Shepherdson M, Connett J, Anthonisen N, Pare P . The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet. 2002; 11(5):569-76. DOI: 10.1093/hmg/11.5.569. View

14.

Artigas M, Wain L, Repapi E, Obeidat M, Sayers I, Burton P . Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med. 2011; 184(7):786-95. PMC: 3398416. DOI: 10.1164/rccm.201102-0192OC. View

15.

Guerra S . Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol. 2009; 9(5):409-16. PMC: 2832909. DOI: 10.1097/ACI.0b013e3283300baf. View

16.

Gui J, Andrew A, Andrews P, Nelson H, Kelsey K, Karagas M . A simple and computationally efficient sampling approach to covariate adjustment for multifactor dimensionality reduction analysis of epistasis. Hum Hered. 2010; 70(3):219-25. PMC: 2982850. DOI: 10.1159/000319175. View

17.

Vibhuti A, Arif E, Deepak D, Singh B, Pasha M . Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD. Biochem Biophys Res Commun. 2007; 359(1):136-42. DOI: 10.1016/j.bbrc.2007.05.076. View

18.

Su M, Tung K, Liang P, Tsai C, Kuo N, Lee Y . Gene-gene and gene-environmental interactions of childhood asthma: a multifactor dimension reduction approach. PLoS One. 2012; 7(2):e30694. PMC: 3280263. DOI: 10.1371/journal.pone.0030694. View

19.

Salam M, Lin P, Avol E, Gauderman W, Gilliland F . Microsomal epoxide hydrolase, glutathione S-transferase P1, traffic and childhood asthma. Thorax. 2007; 62(12):1050-7. PMC: 2094290. DOI: 10.1136/thx.2007.080127. View

20.

Regueiro E, Lorenzo V, Basso R, Pessoa B, Jamami M, Costa D . Relationship of BODE Index to functional tests in chronic obstructive pulmonary disease. Clinics (Sao Paulo). 2009; 64(10):983-8. PMC: 2763073. DOI: 10.1590/S1807-59322009001000008. View